Related Experiment Video
Updated: Mar 13, 2026
16:40
A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
26.9K
Implantable cardioverter defibrillator management: an update
Michele Malagù1, Alessandra Ferri1, Ottavia Mancuso1
1Department of Cardiology, University of Ferrara, S Anna Hospital, Ferrara, Italy.
Future Cardiology
|November 2, 2016
Summary
Implantable cardioverter defibrillators (ICDs) are crucial for preventing sudden cardiac death. This review covers ICD management, from implantation to future perspectives, ensuring optimal patient care.
Area of Science:
- Cardiology
- Medical Devices
- Electrophysiology
Background:
- Implantable cardioverter defibrillators (ICDs) are essential for preventing sudden cardiac death.
- ICD implantation rates have steadily increased over 35 years due to technological advancements and clinical trials.
Purpose of the Study:
- To provide a comprehensive review of current implantable cardioverter defibrillator (ICD) management.
- To discuss all aspects of ICDs, including implantation, follow-up, complications, and future directions.
Main Methods:
- This is a review article, synthesizing existing knowledge and clinical practices.
- The review covers implantation procedures, predischarge care, remote and office monitoring, diagnostic evaluations, and management of specific patient scenarios.
Main Results:
- The review details various aspects of ICD management, including device implantation, patient monitoring, and handling of complications.
- It addresses challenges such as suspected therapies, device malfunctions, heart failure, and peri-procedural management during surgery, radiotherapy, and endoscopic procedures.
- Infections and other complications associated with ICDs are also discussed.
Conclusions:
- Optimal management of ICDs requires a thorough understanding of implantation, follow-up, and potential complications.
- Future perspectives in ICD technology and patient care are highlighted to improve outcomes for patients at risk of sudden cardiac death.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
574
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
574
01:25Dysrhythmias VI: Management of Dysrhythmias
563
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
563
01:29Cardiomyopathy VI: Nursing Management
434
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
434
01:26Cardiac Catheterization IV: Nursing Management
969
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
969
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
1.2K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.2K
01:26Mitral Stenosis III: Medical Management
413
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
413